Literature DB >> 24589706

Human immunodeficiency virus type 1 Vpr increases hepatitis C virus RNA replication in cell culture.

Amei Deng1, Chao Chen1, Yukihito Ishizaka2, Xinwen Chen1, Binlian Sun3, Rongge Yang4.   

Abstract

Human immunodeficiency virus (HIV) coinfection with hepatitis C virus (HCV) is associated with an increased HCV RNA level, as well as a more rapid progression to cirrhosis and end-stage liver disease. However, the mechanism underlying this effect is largely unknown. Here, we investigated the role of HIV-1 Vpr in HCV infection and clearly demonstrated that Vpr increased the replication of both the infectious HCV full-length genome and the subgenomic replicon. We also demonstrated that Vpr increased HCV infection by enhancing RNA replication but not viral entry or translation. Further, we showed that Vpr could partially overcome the anti-HCV effect of PEG-IFN. Our findings not only partially explain the clinical observation that patients coinfected with HIV and HCV have higher levels of HCV RNA and viral load than HCV mono-infected patients but also provide important information for HCV treatment in HIV/HCV coinfected patients.
Copyright © 2014 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Coinfection; Hepatitis C virus; Human immunodeficiency virus; RNA replication; Vpr

Mesh:

Substances:

Year:  2014        PMID: 24589706     DOI: 10.1016/j.virusres.2014.02.017

Source DB:  PubMed          Journal:  Virus Res        ISSN: 0168-1702            Impact factor:   3.303


  7 in total

Review 1.  A Tale of Two Viruses: Immunological Insights Into HCV/HIV Coinfection.

Authors:  Samaa T Gobran; Petronela Ancuta; Naglaa H Shoukry
Journal:  Front Immunol       Date:  2021-08-12       Impact factor: 7.561

Review 2.  Hepatitis C: Treatment of difficult to treat patients.

Authors:  Eric G Hilgenfeldt; Alex Schlachterman; Roberto J Firpi
Journal:  World J Hepatol       Date:  2015-07-28

3.  HIV Vpr protein upregulates microRNA-122 expression and stimulates hepatitis C virus replication.

Authors:  Milin Peng; Xinqiang Xiao; Yan He; Yongfang Jiang; Min Zhang; Feng Peng; Yi Tian; Yun Xu; Guozhong Gong
Journal:  J Gen Virol       Date:  2015-04-28       Impact factor: 3.891

4.  PRO-C3-levels in patients with HIV/HCV-Co-infection reflect fibrosis stage and degree of portal hypertension.

Authors:  Christian Jansen; Diana J Leeming; Mattias Mandorfer; Inger Byrjalsen; Robert Schierwagen; Philipp Schwabl; Morten A Karsdal; Evrim Anadol; Christian P Strassburg; Jürgen Rockstroh; Markus Peck-Radosavljevic; Søren Møller; Flemming Bendtsen; Aleksander Krag; Thomas Reiberger; Jonel Trebicka
Journal:  PLoS One       Date:  2014-09-29       Impact factor: 3.240

5.  HIV-1 Vpr protein upregulates microRNA-210-5p expression to induce G2 arrest by targeting TGIF2.

Authors:  Jialu Qiao; Qian Peng; Feng Qian; Qiang You; Lingyan Feng; Song Hu; Wei Liu; Lixia Huang; Xiji Shu; Binlian Sun
Journal:  PLoS One       Date:  2021-12-29       Impact factor: 3.240

Review 6.  Virological Mechanisms in the Coinfection between HIV and HCV.

Authors:  Maria Carla Liberto; Emilia Zicca; Grazia Pavia; Angela Quirino; Nadia Marascio; Carlo Torti; Alfredo Focà
Journal:  Mediators Inflamm       Date:  2015-10-01       Impact factor: 4.711

7.  RNA Viruses: RNA Roles in Pathogenesis, Coreplication and Viral Load.

Authors:  Palmiro Poltronieri; Binlian Sun; Massimo Mallardo
Journal:  Curr Genomics       Date:  2015-10       Impact factor: 2.236

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.